Rang-du-Fliers, France-based Intech, an orthopedic instruments manufacturer, has entered into an exclusive agreement to acquire Châtellerault, France-based Coulot Decolletage, a medical device manufacturer.
Intech to Acquire Additive Manufacturing Company
1 min read Premium comments
#intechSecondary#coulotdecolletage#francoissamson
Founded more than 20 years ago, Intech manufactures orthopedic products for hip, knee, spine, and trauma surgery. Its product portfolio includes instruments, cases, trays, handles, and implants.
Founded in 1985, Coulot supports medical device companies across the globe by manufacturing implants and prostheses for the spine, extremity, and trauma markets. Coulot also provides additive manufacturing services to support 3D printing projects.
OTW spoke with Intech Group Marketing Director Francois Samson about the acquisition. Samson told OTW, “Intech acquired Coulot in order to further diversify from instrumentation by increasing its footprint into the SET (Spine, Implant & Trauma) implant space to complement its growing exposure to the expandable implants space (complex MIS expandable devices). The combined implant revenue is projected to add up to just shy of 20% of Intech revenue as integration is complete.”
Samson continued, “Also, Coulot’s 3+ years know-how and expertise in additive manufacturing allows the Intech Group to jump start its journey into the 3D printing space. We now have an ATEX room that is set up to scale. Our focus is currently on DMLS (Direct Metal Laser Sintering) leveraging 3D system’s DMP Flex 350 machines and the main product lines we provide are 3D printed cages.”
Intech acquired Coulot for an undisclosed sum. Per the press release, in fiscal year 2021 “the newly consolidated group is expected to generate over $150M [million] in revenue.”
In the press release, Coulot General Manager Bruno Coulot commented, “We are excited to become a part of Intech Group. Delivering best-in-class customer service and helping patients get taken care of is what we are about. It’s exciting that the partnership with Intech allows us to do what we do on a much larger scale.“
This is the first acquisition since Intech announced a partnership with Frankfurt, Germany-based Montagu, a private equity firm. For OTW’s coverage of the partnership, see “Intech Finalizes Partnership With Montagu.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.